ENVOY MEDICAL, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$241K
Cost of Revenue
$874K
R&D
$12M
SG&A
—
D&A
$302K
Operating Income
$-22M
EBITDA
$-22M
Interest Expense
$2M
Interest Income
—
Other Income/Expense
$104K
Pretax Income
$-24M
Tax Provision
—
Net Income
$-24M
Operating Margin
-9240.7%
Net Margin
-9857.3%
Effective Tax Rate
—
Deferred Tax Assets
$808K
Deferred Tax Liabilities
$433K
DTA Valuation Allowance
$50M
Tax Credit Carryforwards
$2M
NOL Carryforwards
$42M
ETR (Continuing Operations)
—
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.2%
Operating Lease Cost
$206K
Revenue YoY Variation
7.1%
Income YoY Variation
-15.7%